Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 3, 2008
Diabetes Care 31:952-957, 2008
DOI: 10.2337/dc07-1926
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-1926v1
31/5/952    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reaven, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reaven, P. D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Research

Proliferative Diabetic Retinopathy in Type 2 Diabetes Is Related to Coronary Artery Calcium in the Veterans Affairs Diabetes Trial (VADT)

Peter D. Reaven, MD1, Nicholas Emanuele, MD2, Thomas Moritz, PHD3, Ronald Klein, MD4, Mathew Davis, MD4, Kathy Glander, BBA4, William Duckworth, MD1, Carlos Abraira, MD5 for the Veterans Affairs Diabetes Trial (VADT)*

1 Carl T. Hayden VA Medical Center, Phoenix, Arizona
2 Edward Hines, Jr., VA Hospital, Hines, Illinois
3 Cooperative Studies Program Coordinating Center, Edward Hines, Jr., VA Hospital, Hines, Illinois
4 University of Wisconsin, Madison, Wisconsin
5 Miami VA Medical Center, Miami, Florida

Corresponding author: Peter Reaven, MD, Phoenix VAMC, 650 E. Indian School Road (111E), Phoenix, AZ 85012-1892. E-mail: peter.reaven{at}va.gov

OBJECTIVE—Increasing evidence suggests that macrovascular disease and retinopathy may be more closely linked than previously believed. We determined the relationship between retinopathy and coronary atherosclerosis as measured by computed tomography–detectable coronary artery calcium (CAC).

RESEARCH DESIGN AND METHODS—The cross-sectional association between CAC and retinopathy was assessed on a Veteran Affairs Diabetes Trial subsample of 204 subjects with a mean duration of type 2 diabetes of 12.3 ± 8.3 years.

RESULTS—Retinopathy was correlated with CAC (r = 0.19, P = 0.006). Median CAC increased across retinopathy categories: 197 in those with no retinopathy, 229 in those with microaneurysms only, 364 in those with mild nonproliferative diabetic retinopathy (NPDR), 300 in those with moderate to severe NPDR, and 981 in those with proliferative diabetic retinopathy (PDR). Stepwise multivariable linear regression analysis was performed to find a parsimonious subset of relevant risk factors to include along with PDR in predicting CAC. After adjustment for either this subset of standard factors (P = 0.047) or a more extensive panel of risk factors (P = 0.035), PDR was significantly associated with CAC. Moreover, using logistic regression, individuals with PDR were approximately sixfold more likely to have CAC >400 than those with no PDR, even after adjustment for other CVD risk factors.

CONCLUSIONS—These data indicate an important relationship between retinopathy and extent of CAC and suggest the potential to identify and treat shared risk factors for these common micro- and macrovascular complications.

Abbreviations: CAC, coronary artery calcium • CVD, cardiovascular disease • NPDR, nonproliferative diabetic retinopathy • PDR, proliferative diabetic retinopathy • VADT, Veterans Affairs Diabetes Trial


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.